NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC	Disease Attributes, Disease Progression, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, renal pelvis/ureter urothelial carcinoma	Not yet recruiting	Phase 2	2026-02-17		NCT07412171

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Friendship Hospital	120
Jiangsu Provincial People's Hospital	19
Peking University Cancer Hospital & Institute	189
Peking University Third Hospital	243
The First Affiliated Hospital of Zhengzhou University	203
The Second Affiliated Hospital of Kunming Medical University	33

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University Third Hospital	Beijing	China	123